Keywords: pfizer, considers, price, cuts, its, new, antidepressant

PFIZER CONSIDERS PRICE CUTS

Article | 29 March 1993

Print This

For Pfizer, its new antidepressant Zoloft (sertraline) produced US revenues approaching $175 million in its first year of marketing, and a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in